← Back to Search

Other

BHV-7000 for Depression

Phase 2
Waitlist Available
Research Sponsored by Biohaven Therapeutics Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 52 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new medication called BHV-7000 to see if it is safe and well-tolerated over several months in people with Major Depressive Disorder. The goal is to help those who suffer from severe depression by potentially offering a new treatment option.

Who is the study for?
This trial is for individuals who have completed the initial phase of parent studies on Major Depressive Disorder (MDD). Women of childbearing potential must not be pregnant, breastfeeding, or lactating and should test negative for pregnancy to participate.
What is being tested?
The study is focused on assessing the long-term safety and tolerability of a medication called BHV-7000 in people with MDD. It aims to understand how well patients can handle this treatment over an extended period.
What are the potential side effects?
While specific side effects are not listed here, generally such trials monitor for any adverse reactions from taking BHV-7000 over time which could include nausea, headaches, sleep disturbances or other drug-related issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 52 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 52 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants With Clinically Significant Laboratory Abnormalities
Number of Participants With Serious AEs (SAEs), AEs Leading to Study Drug Discontinuation, and AEs judged to be related to study medication

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: BHV-7000Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Biohaven Therapeutics Ltd.Lead Sponsor
11 Previous Clinical Trials
4,216 Total Patients Enrolled
1 Trials studying Depression
300 Patients Enrolled for Depression
~320 spots leftby Nov 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top